• Delivering Therapies that
    Enable a Healthier World

  • Inspired by Science

    LOTTE BIOLOGICS is dedicated to improving
    the lives of patients worldwide as a leading global CDMO.

  • Embracing Diversity

    LOTTE BIOLOGICS embraces diversity
    in the pursuit of global well-being.

  • Fostering Talent

    LOTTE BIOLOGICS fosters talent to
    lead global healthcare innovations.

  • Connecting Lives

    LOTTE BIOLOGICS connects people to
    bridge boundaries and promote sustainability.


With expertise that spans from development to clinical and commercial production,
LOTTE BIOLOGICS offers end-to-end CDMO services.


Introducing LOTTE BIOLOGICS' production facilities,
renowned for their top-tier quality and manufacturing capabilities.

Syracuse Site

(New York, USA)

With a manufacturing capacity of 40,000 liters of
Drug Substance, the Syracuse site is also equipped for
storage and quality control capabilities.

Songdo Site

(Incheon, South Korea)

LOTTE BIOLOGICS plans to operate a total of
three plants in Songdo, Incheon with a capacity of
360,000 liters starting from 2030.


Delivering the latest news from LOTTE BIOLOGICS.